Uk Coronavirus Study
- All
- News
- Videos
-
Omicron Less Likely To Cause Long COVID -19: UK Study
The Omicron variant of coronavirus is less likely to cause long COVID than previous variants, according to the first peer-reviewed study of its kind from the United Kingdom.
-
Only 1 In 4 Covid Patients Feel Fully Recovered After A Year: UK Study
A year after having COVID-19, only around one in four hospitalised patients feel fully recovered, according to a UK study published in The Lancet Respiratory Medicine journal which found that the disease affects women worse than men.
-
Common Colds Can Provide Protection Against Covid: UK Study
High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on Monday has found, which could inform approaches for second-generation vaccines.
-
Booster Can Boost Effectiveness Against Omicron To 88%, UK Studies Show
A third dose of COVID-19 vaccine can provide up to 88 per cent protection against hospitalisation from infection by the Omicron variant of coronavirus, according to early results from studies conducted in the UK.
-
Mixing Covid Vaccines Is Effective In Study on Pfizer, AstraZeneca
Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a UK study found.
-
As UK Rollouts Jabs For Children, A Study To Test Mixed Dose Schedules
A British study will look into the immune responses of children to mixed schedules of different COVID-19 vaccines as officials try to determine the best approach to second doses in adolescents given a small risk of heart inflammation.
-
Long Covid Affects Up To 1 In 7 Children Months After Infection: Study
As many as 1 in 7 children may have symptoms linked to the coronavirus months after testing positive for COVID-19, the authors of an English study on long COVID in adolescents said on Wednesday.
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Double Vaccinated? You're 3 Times Less Likely To Get COVID-19, Says Study
People who have received both doses of their coronavirus vaccine are three times less likely to get infected with COVID-19, a latest UK study has found.
-
COVID-19 Linked To Substantial Impact On Intelligence In Recovered Patients: Study
A severe coronavirus infection, involving hospitalisation and ventilator support, has a substantial impact on a recovered patient's intelligence as part of wider "Long-COVID" symptoms, a UK study has found.
-
UK Delta Variant Infections High But Hospitalisations In Check: Study
UK health officials said the Delta variant of COVID-19 continues its rise in the UK with a further 36,800 cases logged on Friday, which marks a 17 per cent increase over the previous week.
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
-
Delta Variant Dominates In UK, Causes More Hospitalisation: 10 Facts
The Delta variant of COVID-19, first found in India, has now emerged as the dominant strain in the UK and may send more to the hospital than before, the country's scientists have said.
-
One Dose Of Covid Vaccine Cuts Household Spread By Up To 50%: UK Study
One dose of the Pfizer or AstraZeneca vaccines reduces the chances of someone infected with coronavirus from spreading it to other household members by up to 50 percent, according to a English study published Wednesday.
-
Omicron Less Likely To Cause Long COVID -19: UK Study
The Omicron variant of coronavirus is less likely to cause long COVID than previous variants, according to the first peer-reviewed study of its kind from the United Kingdom.
-
Only 1 In 4 Covid Patients Feel Fully Recovered After A Year: UK Study
A year after having COVID-19, only around one in four hospitalised patients feel fully recovered, according to a UK study published in The Lancet Respiratory Medicine journal which found that the disease affects women worse than men.
-
Common Colds Can Provide Protection Against Covid: UK Study
High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on Monday has found, which could inform approaches for second-generation vaccines.
-
Booster Can Boost Effectiveness Against Omicron To 88%, UK Studies Show
A third dose of COVID-19 vaccine can provide up to 88 per cent protection against hospitalisation from infection by the Omicron variant of coronavirus, according to early results from studies conducted in the UK.
-
Mixing Covid Vaccines Is Effective In Study on Pfizer, AstraZeneca
Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a UK study found.
-
As UK Rollouts Jabs For Children, A Study To Test Mixed Dose Schedules
A British study will look into the immune responses of children to mixed schedules of different COVID-19 vaccines as officials try to determine the best approach to second doses in adolescents given a small risk of heart inflammation.
-
Long Covid Affects Up To 1 In 7 Children Months After Infection: Study
As many as 1 in 7 children may have symptoms linked to the coronavirus months after testing positive for COVID-19, the authors of an English study on long COVID in adolescents said on Wednesday.
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
-
Double Vaccinated? You're 3 Times Less Likely To Get COVID-19, Says Study
People who have received both doses of their coronavirus vaccine are three times less likely to get infected with COVID-19, a latest UK study has found.
-
COVID-19 Linked To Substantial Impact On Intelligence In Recovered Patients: Study
A severe coronavirus infection, involving hospitalisation and ventilator support, has a substantial impact on a recovered patient's intelligence as part of wider "Long-COVID" symptoms, a UK study has found.
-
UK Delta Variant Infections High But Hospitalisations In Check: Study
UK health officials said the Delta variant of COVID-19 continues its rise in the UK with a further 36,800 cases logged on Friday, which marks a 17 per cent increase over the previous week.
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
-
Delta Variant Dominates In UK, Causes More Hospitalisation: 10 Facts
The Delta variant of COVID-19, first found in India, has now emerged as the dominant strain in the UK and may send more to the hospital than before, the country's scientists have said.
-
One Dose Of Covid Vaccine Cuts Household Spread By Up To 50%: UK Study
One dose of the Pfizer or AstraZeneca vaccines reduces the chances of someone infected with coronavirus from spreading it to other household members by up to 50 percent, according to a English study published Wednesday.
